COSCIENS Biopharma Inc. (CSCIF)

CIK 1113423 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for COSCIENS Biopharma Inc..

Recent SEC filings

FiledFormAccession number
Jul 6, 20266-K0001493152-26-032085
Jul 6, 2026SC 13E3/A0001493152-26-032084
Jul 6, 202615-12G0001493152-26-032172
Jun 23, 2026SC 13E3/A0001493152-26-029667
Jun 23, 20266-K0001493152-26-029666
Jun 18, 20266-K0001493152-26-029205
Jun 18, 2026SC 13E3/A0001493152-26-029198
May 20, 2026SC 13E3/A0001493152-26-024635
May 20, 20266-K0001493152-26-024629
May 12, 2026SC 13E3/A0001493152-26-022542
May 12, 20266-K0001493152-26-022523
May 12, 20266-K0001493152-26-022524
May 8, 20266-K0001493152-26-022001
May 8, 2026SC 13E3/A0001493152-26-022002
May 4, 2026SC 13E3/A0001493152-26-020983
Apr 20, 20266-K0001493152-26-018000
Apr 20, 2026SC 13E30001493152-26-018001
Apr 17, 2026SCHEDULE 13D/A0001493152-26-017950
Apr 7, 20266-K0001493152-26-015557
Mar 25, 202620-F0001493152-26-012703
Mar 25, 20266-K0001493152-26-012702
Mar 18, 2026EFFECT9999999995-26-000843
Mar 18, 2026EFFECT9999999995-26-000852
Mar 18, 2026EFFECT9999999995-26-000847
Mar 18, 2026EFFECT9999999995-26-000844